Search for: "Novartis Pharmaceuticals Corporation "
Results 41 - 60
of 219
Sort by Relevance
|
Sort by Date
11 Dec 2017, 7:39 am
Novartis Pharmaceuticals Corporation, 4-17-cv-04405 (CAND December 7, 2017, Order) (Gilliam, USDJ) [read post]
21 Nov 2017, 2:40 pm
We recommend that the FDA and [Novartis Pharmaceuticals Corporation] the manufacturer [of Entresto] more clearly communicate the full risk of hypotension, including appropriate steps for monitoring patients, and examine whether a more gradual escalation of dose to the recommended level would reduce the risk. [read post]
16 Sep 2016, 4:07 am
In the Actavis case, the applicants similarly argued that Orion’s agreement to supply finished product, or active pharmaceutical ingredients, to Novartis meant that the arrangement did not constitute an exclusive licence. [read post]
30 Aug 2016, 6:49 am
" Novartis Pharmaceuticals Corporation et al v. [read post]
2 Jun 2016, 5:23 am
.; Medical Capital Corporation; Medical Provider Funding Corporation VI; Sidney M. [read post]
30 Nov 2015, 1:25 pm
Novartis Pharmaceuticals Corp., 944 F. [read post]
2 Nov 2015, 2:05 pm
(See, Blog post DOJ to Focus on Individual Accountability for Corporate Fraud.) [read post]
11 Oct 2015, 6:56 am
A final order could be obtained against such a defendant, as had occurred in Novartis Pharmaceuticals UK Ltd v Stop Huntingdon Animal Cruelty & Ors [2014] EWHC 3429 (QB). [read post]
25 Sep 2015, 8:51 am
Novartis Pharmaceuticals Corp., No. 15-cv-0670, 2015 U.S. [read post]
15 Sep 2015, 2:20 pm
This September 2015 Drug Safety Alert Is Based Primarily On Reports Of Skin Cancer And Lymphoma Blood Cancer   (Posted by Tom Lamb at DrugInjuryWatch.com) Health Canada recently conducted a review of safety information obtained from the drug company Novartis Pharmaceuticals Corporation, the manufacturer of Gilenya (fingolimod), about a potential link between the use of this multiple sclerosis (MS) drug and certain types of cancers and malignant tumors or… [read post]
11 Aug 2015, 9:34 am
Andrews in Novartis Pharmaceuticals Corp., et al. v. [read post]
6 Aug 2015, 2:08 pm
As regards the resulting August 2015 revision to the Gilenya Prescribing Information (also known as "package insert" and "drug label"), the FDA SUPPLEMENT APPROVAL letter (8/4/15) to Novartis Pharmaceuticals Corporation sets the stage: This supplemental application provides for addition of a new subsection to the Warnings and Precautions section of the prescribing information; the new subsection [5.3] describes the cases of progressive multifocal… [read post]
2 Mar 2015, 2:43 pm
ZTE Corporation is ramping up to take advantage of the new legal environment that has resulted from the settlement between Qualcomm and the Chinese National Development and Reform Commission (NDRC) over claims that the company’s licensing practices had violated the country’s Anti-Monopoly Law, recounts Neil.* Groundless threats to sue for IP infringement: the end of an era? [read post]
30 Jun 2014, 4:23 am
Milliken & Company Northrop Grumman Corporation Novartis Patent Café.com, Inc. [read post]
30 Apr 2014, 4:30 am
Novartis Pharmaceuticals Corp., 2014 U.S. [read post]
18 Apr 2014, 11:00 am
Novartis Pharmaceuticals Corp., No. 13-15433, 2014 U.S. [read post]
18 Mar 2014, 9:13 am
In addition, in July 2010, FDA issued an untitled letter to Novartis Pharmaceuticals Corporation relating to the “Facebook Share” widget on its Tasigna® product website. [read post]
12 Mar 2014, 12:43 pm
Novartis Pharmaceuticals Corporation, et al. v. [read post]
19 Feb 2014, 6:57 am
• Novartis Pharmaceuticals Corporation • Pfizer, Inc. [read post]
24 Jan 2014, 10:32 pm
Novartis v. [read post]
